Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

GSK drug helps ovarian cancer patients live longer

GlaxoSmithKline Plc’s cancer treatment Zejula met the main goal of helping patients with ovarian cancer live longer without their disease worsening in a late-stage study, the company said.

Read More »

Novartis, Amgen and Banner End Alzheimer’s Program

Novartis, Amgen and the Banner Alzheimer’s Institute announced they are halting two pivotal Phase II/III clinical trials in the Alzheimer’s Prevention Initiative Generation Program.

Read More »

New Insights into the Vagus Nerve Could Change the Way Diabetes is Treated

A new discovery at the Feinstein Institutes for Medical Research could have implications in the way diabetes is treated in the future.

Read More »

Studies Show Sarepta’s Exondys 51 Slows Respiratory Decline in Muscular Dystrophy Patients

Research from three clinical trials supports that Sarepta Therapeutics’ Exondys 51 slows respiratory decline in DMD.

Read More »

Two-drug HIV treatment Dovato meets main study goal

GlaxoSmithKline Plc’s two-drug HIV regimen Dovato was successful in suppressing the AIDS-causing virus in patients over 48 weeks at the same level of a previous three-drug treatment in a late-stage trial.

Read More »

Intra-Cellular drug fails bipolar depression study

Intra-Cellular Therapies Inc.’s lead drug failed to meet the main goal of a late-stage study in patients with major depressive episodes associated with bipolar disorder.

Read More »

Weightlifting better at reducing heart fat than aerobic exercise

Obese people who engaged in resistance training were more likely to see reductions in a type of heart fat, a new study finds.

Read More »

Most older adults with ‘prediabetes’ don’t develop diabetes

Older adults with slightly elevated blood sugar – sometimes called “prediabetes” – usually do not develop full-blown diabetes, a Swedish study suggests.

Read More »

Pfizer Reports Failure in PPHN, Progress in DMD

Pfizer’s IV Revatio, when added to inhaled nitric oxide, failed to meet the primary efficacy endpoint in treating newborns with persistent pulmonary hypertension in a Phase III study.

Read More »

Using Stem Cells to “Cure” Baldness

Researchers with Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, were able to grow natural-looking hair that grows through the skin using human induced pluripotent stem cells (iPSCs).

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom